These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 30316766

  • 21. CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemia.
    Zhang T, Ma D, Wei D, Lu T, Yu K, Zhang Z, Wang W, Fang Q, Wang J.
    Anticancer Drugs; 2020 Feb; 31(2):158-168. PubMed ID: 31584454
    [Abstract] [Full Text] [Related]

  • 22. VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia.
    Toosi B, Zaker F, Alikarami F, Kazemi A, Teremmahi Ardestanii M.
    Biomed Pharmacother; 2018 Jun; 102():428-437. PubMed ID: 29574283
    [Abstract] [Full Text] [Related]

  • 23. Anti-leukemic effect of PI3K inhibition on chronic myeloid leukemia (CML) cells: shedding new light on the mitigating effect of c-Myc and autophagy on BKM120 cytotoxicity.
    Shiri Heris R, Safaroghli-Azar A, Yousefi AM, Hamidpour M, Bashash D.
    Cell Biol Int; 2020 May; 44(5):1212-1223. PubMed ID: 32068318
    [Abstract] [Full Text] [Related]

  • 24. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
    Chiu HW, Ho YS, Wang YJ.
    J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
    [Abstract] [Full Text] [Related]

  • 25. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS, Cheong HJ, Kim SJ, Kim KH, Lee N, Park HS, Won JH.
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [Abstract] [Full Text] [Related]

  • 26. Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
    Roszak J, Smok-Pieniążek A, Stępnik M.
    Adv Clin Exp Med; 2017 Dec; 26(9):1335-1342. PubMed ID: 29442453
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species.
    Mesbahi Y, Zekri A, Ghaffari SH, Tabatabaie PS, Ahmadian S, Ghavamzadeh A.
    Eur J Pharmacol; 2018 Sep 05; 834():65-76. PubMed ID: 30012499
    [Abstract] [Full Text] [Related]

  • 30. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
    Redondo-Muñoz J, Escobar-Díaz E, Hernández Del Cerro M, Pandiella A, Terol MJ, García-Marco JA, García-Pardo A.
    Clin Cancer Res; 2010 Sep 01; 16(17):4382-91. PubMed ID: 20534739
    [Abstract] [Full Text] [Related]

  • 31. Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function.
    Blanco B, Herrero-Sánchez C, Rodríguez-Serrano C, Sánchez-Barba M, Del Cañizo MC.
    Int Immunopharmacol; 2015 Sep 01; 28(1):675-85. PubMed ID: 26256696
    [Abstract] [Full Text] [Related]

  • 32. Arsenic trioxide regulates the glycolytic pathway to treat acute promyelocytic leukemia by inhibiting RPL22L1.
    Cui H, Ma Y, Han S, Zhang X, Fu W, Yang S, Liu T, Zhang X.
    Leuk Res; 2024 Sep 01; 144():107550. PubMed ID: 39079325
    [Abstract] [Full Text] [Related]

  • 33. Targeting human telomerase RNA component using antisense oligonucleotide induces rapid cell death and increases ATO-induced apoptosis in APL cells.
    Asghari-Kia L, Bashash D, Safaroghli-Azar A, Momeny M, Hamidpour M, Ghaffari SH.
    Eur J Pharmacol; 2017 Aug 15; 809():215-223. PubMed ID: 28533173
    [Abstract] [Full Text] [Related]

  • 34. Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines.
    Mueller A, Bachmann E, Linnig M, Khillimberger K, Schimanski CC, Galle PR, Moehler M.
    Cancer Chemother Pharmacol; 2012 Jun 15; 69(6):1601-15. PubMed ID: 22543857
    [Abstract] [Full Text] [Related]

  • 35. Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells.
    Hu Y, Guo R, Wei J, Zhou Y, Ji W, Liu J, Zhi X, Zhang J.
    Cell Death Dis; 2015 Dec 17; 6(12):e2020. PubMed ID: 26673665
    [Abstract] [Full Text] [Related]

  • 36. Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status.
    Bashash D, Sayyadi M, Safaroghli-Azar A, Sheikh-Zeineddini N, Riyahi N, Momeny M.
    Int J Biochem Cell Biol; 2019 Mar 17; 108():7-16. PubMed ID: 30639430
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma.
    Zang C, Eucker J, Liu H, Coordes A, Lenarz M, Possinger K, Scholz CW.
    Leuk Lymphoma; 2014 Feb 17; 55(2):425-34. PubMed ID: 23721513
    [Abstract] [Full Text] [Related]

  • 38. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
    Qu H, Tong D, Zhang Y, Kang K, Zhang Y, Chen L, Ren L.
    Pharmazie; 2013 Oct 17; 68(10):839-45. PubMed ID: 24273890
    [Abstract] [Full Text] [Related]

  • 39. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
    Kim HJ, Lee SY, Kim CY, Kim YH, Ju W, Kim SC.
    Oncotarget; 2017 Jan 24; 8(4):6608-6622. PubMed ID: 28036259
    [Abstract] [Full Text] [Related]

  • 40. Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Vivas-Mejía PE, Ozpolat B, Chen X, Lopez-Berestein G.
    Int J Cancer; 2009 Jul 15; 125(2):264-75. PubMed ID: 19408305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.